Kiltearn Partners’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.2M Buy
405,782
+27,777
+7% +$940K 3.18% 11
2026
Q2
$10.4M Buy
378,005
+287,455
+317% +$9.44M 2.52% 15
2026
Q1
$3.37M Sell
90,550
-17,800
-16% -$733K 0.91% 23
2025
Q4
$5.07M Sell
108,350
-21,600
-17% -$934K 1.1% 26
2025
Q3
$5.44M Sell
129,950
-9,000
-6% -$396K 1.09% 28
2025
Q2
$6.12M Sell
138,950
-9,800
-7% -$444K 1.23% 26
2025
Q1
$7.49M Sell
148,750
-25,900
-15% -$1.28M 1.43% 23
2024
Q4
$7.5M Sell
174,650
-20,600
-11% -$869K 1.24% 29
2024
Q3
$7.66M Sell
195,250
-11,650
-6% -$421K 1.04% 28
2024
Q2
$6.66M Buy
+206,900
New +$6.67M 0.81% 31

Other funds holding G

Kiltearn Partners's G Position: Q3 2026 in Review

Kiltearn Partners increased its Genpact (G) stake by 7.3% in Q3 2026, buying an estimated $940K and bringing the position to 405,782 shares worth $13.2M. The position accounts for 3.18% of the portfolio, ranked #11.

Kiltearn Partners first reported a position in G in Q2 2024 and has held it in 10 quarters since. 489 funds tracked by Wall St. Rank hold G as of Q3 2026.

  • Kiltearn Partners held 405,782 shares of Genpact worth $13.2M as of Q3 2026.
  • Kiltearn Partners bought 27,777 Genpact shares in Q3 2026, an estimated $940K.
  • Genpact made up 3.18% of Kiltearn Partners's portfolio in Q3 2026, its #11 holding.
  • Kiltearn Partners first reported a position in Genpact in Q2 2024 and has held it in 10 quarters since.
  • 489 funds tracked by Wall St. Rank held Genpact as of Q3 2026.

Based on Kiltearn Partners's 13F filing for Q3 2026, filed 13 Nov 2026.